Centerra Gold Inc (CG)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 28.32 |
|---|---|
| 52-week range | 14.65 – 33.94 |
| Return, 1 month / 3 months | −11.1% / +24.0% |
| Return, 1 year / 3 years | +81.9% / +440.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 51.5% |
| Worst drawdown (1 year) | -28.0% |
| Average daily value traded | 19.64M CAD |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Centerra Gold is a Canadian mining company that explores for, develops and operates gold mines. Its operations include the Mount Milligan mine in British Columbia and the Oksut mine in Turkey, and it also produces copper as a by-product at some sites. The company is based in Toronto and its customers are mainly metals refiners and traders who purchase gold doré and copper concentrate from its mines.
Centerra Gold Inc trades under the code CG on the Toronto Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Centerra Gold Inc (CG) trades on the Toronto Exchange in Canada. It last closed at CAD 28.32 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 139 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 81.9% and over the last three months it rose 24.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.9% | ||
| From 52-week high | -15.8% | ||
| Momentum | 87 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 24.0% | ||
| 6-month return | 11.6% | ||
| 12-month return, skipping the last month | 104.7% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 51.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.0% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 19.64M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −9.2% |
|---|---|
| 1 month | −11.1% |
| 3 months | +24.0% |
| 6 months | +11.6% |
| 1 year | +81.9% |
| 3 years | +440.0% |
| 5 years | +401.9% |
Signals
| 50-day / 200-day average | 31.26 / 26.02 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Aug 2026 | CAD 0.0700 |
| 21 May 2026 | CAD 0.0700 |
| 12 Mar 2026 | CAD 0.0700 |
| 13 Nov 2025 | CAD 0.0700 |
| 21 Aug 2025 | CAD 0.0700 |
| 22 May 2025 | CAD 0.0700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.